Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3048% below fair value
$43.03−0.66 (-1.51%)
Close on Nov 17, 2026Market cap $62.36BP/E 17.4Yield –
Boston Scientific revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Boston Scientific's revenue for the twelve months ending Jun 30, 2026 was $21.00B, up 13.5% year over year. For fiscal 2025 it was $20.07B, up 19.9% from the year before. Over ten years it grew 10.4% a year on average. The highest annual figure on record is $20.07B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.07B | +19.9% |
| FY2024 | Dec 31, 2024 | $16.75B | +17.6% |
| FY2023 | Dec 31, 2023 | $14.24B | +12.3% |
| FY2022 | Dec 31, 2022 | $12.68B | +6.7% |
| FY2021 | Dec 31, 2021 | $11.89B | +19.9% |
| FY2020 | Dec 31, 2020 | $9.91B | -7.7% |
| FY2019 | Dec 31, 2019 | $10.74B | +9.3% |
| FY2018 | Dec 31, 2018 | $9.82B | +8.6% |
| FY2017 | Dec 31, 2017 | $9.05B | +7.9% |
| FY2016 | Dec 31, 2016 | $8.39B | +12.2% |
| FY2015 | Dec 31, 2015 | $7.48B | +0.2% |
| FY2014 | Dec 31, 2014 | $7.46B | +5.5% |
| FY2013 | Dec 31, 2013 | $7.07B | +1.6% |
| FY2012 | Dec 31, 2012 | $6.96B | -8.7% |
| FY2011 | Dec 31, 2011 | $7.62B | -2.4% |
| FY2010 | Dec 31, 2010 | $7.81B | -4.7% |
| FY2009 | Dec 31, 2009 | $8.19B | +1.7% |
| FY2008 | Dec 31, 2008 | $8.05B | -3.7% |
| FY2007 | Dec 31, 2007 | $8.36B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.44B | +7.5% |
| Q1 FY2026 | Mar 31, 2026 | $5.20B | +11.6% |
| Q4 FY2025 | Dec 31, 2025 | $5.29B | +15.9% |
| Q3 FY2025 | Sep 30, 2025 | $5.07B | +20.3% |
| Q2 FY2025 | Jun 30, 2025 | $5.06B | +22.8% |
| Q1 FY2025 | Mar 31, 2025 | $4.66B | +20.9% |
| Q4 FY2024 | Dec 31, 2024 | $4.56B | +22.4% |
| Q3 FY2024 | Sep 30, 2024 | $4.21B | +19.3% |
| Q2 FY2024 | Jun 30, 2024 | $4.12B | +14.5% |
| Q1 FY2024 | Mar 31, 2024 | $3.86B | +13.8% |
| Q4 FY2023 | Dec 31, 2023 | $3.73B | +14.9% |
| Q3 FY2023 | Sep 30, 2023 | $3.53B | +11.3% |
| Q2 FY2023 | Jun 30, 2023 | $3.60B | +10.9% |
| Q1 FY2023 | Mar 31, 2023 | $3.39B | +12.0% |
| Q4 FY2022 | Dec 31, 2022 | $3.24B | +3.7% |
| Q3 FY2022 | Sep 30, 2022 | $3.17B | +8.1% |
| Q2 FY2022 | Jun 30, 2022 | $3.24B | +5.4% |
| Q1 FY2022 | Mar 31, 2022 | $3.03B | +10.0% |
| Q4 FY2021 | Dec 31, 2021 | $3.13B | +15.4% |
| Q3 FY2021 | Sep 30, 2021 | $2.93B | +10.3% |
| Q2 FY2021 | Jun 30, 2021 | $3.08B | +53.6% |
| Q1 FY2021 | Mar 31, 2021 | $2.75B | +8.2% |
| Q4 FY2020 | Dec 31, 2020 | $2.71B | -6.7% |
| Q3 FY2020 | Sep 30, 2020 | $2.66B | -1.8% |
| Q2 FY2020 | Jun 30, 2020 | $2.00B | -23.9% |
| Q1 FY2020 | Mar 31, 2020 | $2.54B | +2.0% |
| Q4 FY2019 | Dec 31, 2019 | $2.90B | +13.4% |
| Q3 FY2019 | Sep 30, 2019 | $2.71B | +13.1% |
| Q2 FY2019 | Jun 30, 2019 | $2.63B | +5.7% |
| Q1 FY2019 | Mar 31, 2019 | $2.49B | +4.8% |
| Q4 FY2018 | Dec 31, 2018 | $2.56B | +6.4% |
| Q3 FY2018 | Sep 30, 2018 | $2.39B | +7.7% |
| Q2 FY2018 | Jun 30, 2018 | $2.49B | +10.3% |
| Q1 FY2018 | Mar 31, 2018 | $2.38B | +10.1% |
| Q4 FY2017 | Dec 31, 2017 | $2.41B | +11.2% |
| Q3 FY2017 | Sep 30, 2017 | $2.22B | +6.0% |
| Q2 FY2017 | Jun 30, 2017 | $2.26B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.16B | – |
| Q4 FY2016 | Dec 31, 2016 | $2.17B | – |
| Q3 FY2016 | Sep 30, 2016 | $2.10B | – |
See a number that looks wrong?